Skip to Main Content

Paper Details

A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer.
Prostate Cancer Prostatic Dis
13
2022
Author NameAffiliation
Jiaoti HuangDuke University
  • 1 - 1

Datasets

Release 1.2